Lombard Odier Asset Management (Switzerland) SA - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (Switzerland) SA ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$4,121,000
-61.6%
542,183
-48.4%
0.32%
-52.8%
Q4 2021$10,720,000
-16.9%
1,049,947
+9.2%
0.68%
-14.6%
Q3 2021$12,898,000
-27.9%
961,139
+17.9%
0.80%
-11.7%
Q2 2021$17,888,000
+23.6%
815,316
+35.5%
0.91%
-5.5%
Q1 2021$14,474,000601,5910.96%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders